Summary[1]Edit

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan. The company offers protein drugs and formulations of molecule products; and develops biobetters and specialty injectables. Its product portfolio includes film coated, Virapine, and Efanzy tablets, as well as Terbutaline; and Levetir concentrate solution for infusion. The company was founded in 2014 and is based in Hsinchu City, Taiwan.

References and notesEdit

  1. Source: Yahoo Finance.